Xiaoming Yang
Corporate Officer/Principal chez TRANSCENTA HOLDING LIMITED
Profil
Xiaoming Yang's current job is as an Executive VP-Process & Product Development at Transcenta Holding Ltd.
Dr. Yang's former jobs include being a Scientific Director-Process & Product Development at Amgen, Inc. from 2003 to 2013, and being the Head-Commercial Production at Allergan Ltd.
(Ireland) from 2001 to 2003.
Dr. Yang's education history includes a doctorate degree from Rutgers State University of New Jersey in 2001, an undergraduate degree from Chengdu University of Science & Technology in 1984, and an undergraduate degree from the Institute of Process Engineering in 1987.
Postes actifs de Xiaoming Yang
Sociétés | Poste | Début |
---|---|---|
TRANSCENTA HOLDING LIMITED | Corporate Officer/Principal | 01/02/2021 |
Anciens postes connus de Xiaoming Yang
Sociétés | Poste | Fin |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/06/2013 |
ALLERGAN PLC | Corporate Officer/Principal | 01/06/2003 |
Formation de Xiaoming Yang
Chengdu University of Science & Technology | Undergraduate Degree |
Institute of Process Engineering | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
AMGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |